Getinge AB (GNGBY)
19.53
+0.01
(+0.05%)
USD |
OTCM |
May 13, 12:59
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 5.319B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -16.44% |
Valuation | |
PE Ratio | 24.70 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.747 |
Price to Book Value | 1.751 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.4025 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.2026 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 66.67% |
Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%. |
URL | https://www.getinge.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Jul. 18, 2024 (est.) |
Last Earnings Release | Apr. 22, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 23, 2024 |
Ratings
Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%. |
URL | https://www.getinge.com |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Mid Cap/Blend |
Next Earnings Release | Jul. 18, 2024 (est.) |
Last Earnings Release | Apr. 22, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Apr. 23, 2024 |